Stoke Therapeutics Inc (STOK)
11.49
+0.22
(+1.95%)
USD |
NASDAQ |
Jan 03, 16:00
11.49
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Profit Margin (Quarterly): -540.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics Inc | 29.96% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -55.64% |
| Return on Assets | -41.37% |
| Return on Invested Capital | -55.64% |
| Operating Margin (Quarterly) | -613.1% |
| Return on Net Operating Assets | -493.1% |